BDH-Klinik Elzach gGmbH
- Address
- lock Available on a paid plan
Neurology and Pain Research
At BDH-Klinik Elzach gGmbH, the clinical trial activity focuses on neurological early rehabilitation and pain-related disorders, with studies centered on pathological conditions, signs and symptoms linked to persistent nerve pain.
- Chronic pain due to traumatic or post-operative peripheral neuropathy
- Chronic pain due to central neuropathy of any genesis
- Evaluating a treatment approach as an add-on option for people living with difficult-to-manage neuropathic pain
The research is aimed at understanding whether new supportive therapies can improve pain control and overall treatment effectiveness for patients affected by long-lasting nerve damage.
Neuropathic Pain Treatment Studies
This site in Elzach, Germany is conducting a small but focused set of trials in neuropathy, exploring ways to better address pain caused by injury, surgery, or central nervous system conditions.
- Peripheral neuropathic pain after trauma or surgery
- Central neuropathic pain
- Testing whether an additional therapy can improve symptom relief and tolerability in these patient groups
The clinical research here is designed to support better management of chronic nerve pain and to refine treatment options for patients in rehabilitation settings.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Apurano Pharmaceuticals GmbH2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in BDH-Klinik Elzach gGmbH
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Tolerability of AP707 in Patients with chronic pain due to central Neuropathy of any Genesis | Apurano Pharmaceuticals GmbH | Phase III | Not Recruiting | Nov 2023 | Mar 2026 |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Adezunap | 2 | Unknown | 2023-11-02 | 2023-11-02 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.